Nea Management Company, LLC Verona Pharma PLC Transaction History
Nea Management Company, LLC
- $1.31 Billion
- Q3 2024
A detailed history of Nea Management Company, LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Nea Management Company, LLC holds 5,584,753 shares of VRNA stock, worth $253 Million. This represents 12.27% of its overall portfolio holdings.
Number of Shares
5,584,753
Previous 5,584,753
-0.0%
Holding current value
$253 Million
Previous $80.8 Million
98.96%
% of portfolio
12.27%
Previous 7.62%
Shares
5 transactions
Others Institutions Holding VRNA
# of Institutions
167Shares Held
68.7MCall Options Held
704KPut Options Held
685K-
Perceptive Advisors LLC New York, NY6.32MShares$286 Million4.75% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.01MShares$227 Million2.01% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx4.22MShares$191 Million2.52% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$161 Million14.95% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$153 Million5.24% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $2.76B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...